03.04.25 -- ADC Manufacturing's Biggest CMC Challenges And Ways To Approach Them

Treating advocacy as an institutional priority provides tangible benefits for Aldevron’s team members, our clients, and, most importantly, the patients waiting for these potential breakthroughs.

The greatest challenge in drug development can be finding a team capable of carrying a molecule through the complexities that lie between the research lab and the patient’s bedside. Discover three considerations that build a foundation for partnership.

A properly executed virtual audit facilitates thorough qualification, condenses production timelines, enhances relationship-building, and provides early insight into a CDMO’s capability and expertise.

If you are wondering when to begin your CDMO search, the answer is simple: the sooner the better. Partnering with a CDMO early helps ensure later success.

Explore how KBI Biopharma’s SUREtechnology Platform, powered by Selexis, accelerates the development of complex biologics from early stages to first-in-human (FIH) trials, focusing on both speed and quality.

Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

For emerging biotechs looking to refine their development processes and boost their chances of commercial success, exploring these partnership opportunities could prove invaluable.